Johnathan Cooper‐Knock

7.4k total citations
69 papers, 2.2k citations indexed

About

Johnathan Cooper‐Knock is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Johnathan Cooper‐Knock has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Neurology, 27 papers in Genetics and 24 papers in Molecular Biology. Recurrent topics in Johnathan Cooper‐Knock's work include Amyotrophic Lateral Sclerosis Research (49 papers), Neurogenetic and Muscular Disorders Research (27 papers) and Parkinson's Disease Mechanisms and Treatments (15 papers). Johnathan Cooper‐Knock is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (49 papers), Neurogenetic and Muscular Disorders Research (27 papers) and Parkinson's Disease Mechanisms and Treatments (15 papers). Johnathan Cooper‐Knock collaborates with scholars based in United Kingdom, United States and Netherlands. Johnathan Cooper‐Knock's co-authors include Pamela J. Shaw, Janine Kirby, J. Robin Highley, Paul R. Heath, Adrian Higginbottom, Paul G. Ince, Guillaume M. Hautbergue, Stephen B. Wharton, Christopher McDermott and Laura Ferraiuolo and has published in prestigious journals such as The Lancet, Nature Biotechnology and PLoS ONE.

In The Last Decade

Johnathan Cooper‐Knock

66 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johnathan Cooper‐Knock United Kingdom 25 1.4k 963 836 369 348 69 2.2k
Hitoshi Warita Japan 32 1.1k 0.8× 1.0k 1.1× 646 0.8× 394 1.1× 329 0.9× 113 2.4k
Atsushi Shiga Japan 22 954 0.7× 780 0.8× 441 0.5× 319 0.9× 224 0.6× 62 1.8k
Yongping Chen China 23 1.2k 0.9× 530 0.6× 463 0.6× 348 0.9× 252 0.7× 121 1.7k
Meraida Polak United States 18 1.6k 1.2× 1.4k 1.4× 1.2k 1.4× 313 0.8× 334 1.0× 24 2.8k
Jennifer Gass United States 17 1.2k 0.8× 777 0.8× 360 0.4× 310 0.8× 649 1.9× 36 2.1k
Emma M. Corr United States 11 869 0.6× 798 0.8× 469 0.6× 245 0.7× 259 0.7× 17 2.0k
Michael L. Garcia United States 20 1.1k 0.8× 850 0.9× 749 0.9× 423 1.1× 347 1.0× 37 2.2k
Youn‐Bok Lee United Kingdom 22 769 0.6× 1.2k 1.2× 462 0.6× 132 0.4× 210 0.6× 39 1.9k
Ericka Simpson United States 15 757 0.5× 552 0.6× 518 0.6× 313 0.8× 188 0.5× 26 1.6k
Gerald Goodall United Kingdom 15 801 0.6× 457 0.5× 358 0.4× 321 0.9× 317 0.9× 19 1.3k

Countries citing papers authored by Johnathan Cooper‐Knock

Since Specialization
Citations

This map shows the geographic impact of Johnathan Cooper‐Knock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnathan Cooper‐Knock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnathan Cooper‐Knock more than expected).

Fields of papers citing papers by Johnathan Cooper‐Knock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnathan Cooper‐Knock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnathan Cooper‐Knock. The network helps show where Johnathan Cooper‐Knock may publish in the future.

Co-authorship network of co-authors of Johnathan Cooper‐Knock

This figure shows the co-authorship network connecting the top 25 collaborators of Johnathan Cooper‐Knock. A scholar is included among the top collaborators of Johnathan Cooper‐Knock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnathan Cooper‐Knock. Johnathan Cooper‐Knock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Brien, David, Kriti Gupta, Thomas Julian, et al.. (2025). Extreme exercise in males is linked to mTOR signalling and onset of amyotrophic lateral sclerosis. Brain. 148(10). 3652–3664. 2 indexed citations
2.
Badger, Shirlene, Ian Coldicott, Adrian Higginbottom, et al.. (2025). A bacterial artificial chromosome mouse model of amyotrophic lateral sclerosis manifests ‘space cadet syndrome’ on two FVB backgrounds. Disease Models & Mechanisms. 18(2).
3.
Simpson, Julie E., Charlotte Dawson, Delphine Boche, et al.. (2025). Human amyotrophic lateral sclerosis/motor neuron disease: The disease‐associated microglial pathway is upregulated while APOE genotype governs risk and survival. Brain Pathology. 35(6). e70019–e70019. 1 indexed citations
4.
Julian, Thomas, A. A. Roger Thompson, Christopher J. Rhodes, et al.. (2024). Mendelian Randomization Study With Clinical Follow‐Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension. Journal of the American Heart Association. 13(6). e032256–e032256. 6 indexed citations
5.
Shaw, Pamela J. & Johnathan Cooper‐Knock. (2024). Physical Activity as a Risk Factor for Amyotrophic Lateral Sclerosis. Neurology. 103(2). e209689–e209689. 1 indexed citations
6.
Benatar, Michael, Terry Heiman‐Patterson, Johnathan Cooper‐Knock, et al.. (2024). Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD. Journal of Neurology Neurosurgery & Psychiatry. 96(3). 209–218. 8 indexed citations
7.
Chapman, Laura, Johnathan Cooper‐Knock, & Pamela J. Shaw. (2023). Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence. Brain. 146(5). 1745–1757. 31 indexed citations
8.
Julian, Thomas, Eleanor Sanderson, Hui Guo, et al.. (2023). Causal factors in primary open angle glaucoma: a phenome-wide Mendelian randomisation study. Scientific Reports. 13(1). 9984–9984. 10 indexed citations
9.
Moll, Tobias, Valerie Odon, Calum Harvey, et al.. (2022). Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication. Life Science Alliance. 6(1). e202201449–e202201449. 3 indexed citations
10.
Julian, Thomas, Adrian Barry, Tobias Moll, et al.. (2021). Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. EBioMedicine. 68. 103397–103397. 84 indexed citations
11.
Boche, Delphine, et al.. (2020). Review: Microglia in motor neuron disease. Neuropathology and Applied Neurobiology. 47(2). 179–197. 20 indexed citations
12.
Zhang, Sai, Johnathan Cooper‐Knock, Annika K. Weimer, et al.. (2020). Genome-Wide Identification of the Genetic Basis of Amyotrophic Lateral Sclerosis. SSRN Electronic Journal. 1 indexed citations
13.
Kukharsky, Michail S., Natalia Ninkina, Haiyan An, et al.. (2020). Long non-coding RNA Neat1 regulates adaptive behavioural response to stress in mice. Translational Psychiatry. 10(1). 171–171. 53 indexed citations
14.
Goodall, Gerald, Chunfang Wang, Johnathan Cooper‐Knock, et al.. (2019). Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier. International Journal of Molecular Sciences. 20(12). 3097–3097. 21 indexed citations
15.
Waller, Rachel, Gerald Goodall, Marta Milo, et al.. (2017). Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Neurobiology of Aging. 55. 123–131. 111 indexed citations
16.
Cooper‐Knock, Johnathan, Joanna J. Bury, Paul R. Heath, et al.. (2015). C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis. PLoS ONE. 10(5). e0127376–e0127376. 77 indexed citations
17.
Bayatti, Nadhim, Johnathan Cooper‐Knock, Joanna J. Bury, et al.. (2014). Comparison of Blood RNA Extraction Methods Used for Gene Expression Profiling in Amyotrophic Lateral Sclerosis. PLoS ONE. 9(1). e87508–e87508. 22 indexed citations
18.
Cooper‐Knock, Johnathan, J. Robin Highley, Judith Hartley, et al.. (2013). Neurodegeneration caused by intronic expansions of C9ORF72 is a clinically heterogeneous but pathologically distinct disease. The Lancet. 381. S32–S32. 1 indexed citations
19.
Jones, Ashley, Ione Woollacott, Aleksey Shatunov, et al.. (2013). Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat. Neurobiology of Aging. 34(9). 2234.e1–2234.e7. 16 indexed citations
20.
Cooper‐Knock, Johnathan, et al.. (2011). Early Diagnosis of Horner Syndrome Using Topical Apraclonidine. Journal of Neuro-Ophthalmology. 31(3). 214–216. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitoshi Warita Breakdown of academic impact, for papers by Atsushi Shiga Breakdown of academic impact, for papers by Yongping Chen Breakdown of academic impact, for papers by Meraida Polak Breakdown of academic impact, for papers by Jennifer Gass Breakdown of academic impact, for papers by Emma M. Corr Breakdown of academic impact, for papers by Michael L. Garcia Breakdown of academic impact, for papers by Youn‐Bok Lee Breakdown of academic impact, for papers by Ericka Simpson Breakdown of academic impact, for papers by Gerald Goodall
Rankless by CCL
2026